Skip to main content
. 2016 May 31;6:26983. doi: 10.1038/srep26983

Table 1. General characteristics of prospective studies of dietary or serum beta-carotene and all-cause mortality (1997–2016).

No. First author, year Country Cohort or Location Response rate Follow-up years Follow-up rate Cohort size No. of death Baseline age (year) Exposure measurement Median Quantity Sex Adjustment
1 Stepaniak, 2016 Eastern Europe HAPIEE study 59.00% 7.2 95.60% 26993 2371 45–69 Validated FFQ 7404.7 ug/d Quintile 5 vs. Q1; 13955.3/3189.5 Both Age, country, education, smoking status, alcohol intake, body mass index, hypertension, diabetes, hypercholesterolemia, history of cadiovascular disease or cancer, total energy intake
2 Henríquez-Sánchez, 2016 Spain PREDIMED study Not available 4.3 97.20% 7015 319 M: 55–80 F: 60–80 Validated FFQ Not available Quintile 5 vs. Q1 Both Recruitment center, intervention group, age, sex, education, marital status,body mass index, smoking habit, alcohol consumption, total energy intake, energy-adjusted intake of saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids and glycemic index and medical history of hypertension, diabetes, dyslipidemia and cancer.
3 Roswall, 2012 Danmark DCH study 35.50% 13.8 100.00% 55453 6767 50–64 Validated FFQ 3205.4 ug/d Highest vs. Lowest group; >4798/<1317 Both Age, alcohol intake, body mass index, waist circumference, smoking status, smoking duration, smoking intensity, time since cessation, education, and physical activity, vitamin E, vitamin C, folic acid, vitamin supplementation.
4 Agudo, 2008 Spain EPIC-Spain 55%-60% 6.5 100.00% 41358 562 30–69 Validated dietary histogoty 1678.6 ug/d Quartile 4 vs. Q1; 3707.2/830.4 Both Age, sex, total energy intake, education, body mass index, physical activity, cigarette smoking, and alcohol consumption.
5 Genkinger, 2004 US CLUE cohort studies 86.00% 12.2 97.00% 6151 910 30–93 FFQ 1697.0 ug/d Quintile 5 vs. Q1; 3884.8/679.2 Both Age, smoking status, body mass index, cholesterol concentration, and energy.
6 Fletcher, 2003 UK Substudy of a randomized trial 47%(Dietary); 52%(Plasma) 4.4 100.00% 1175 290 75–84 FFQ 2154 ug/d Quintile 5 vs. Q1; Both Age, sex, total energy intake, body mass index, cholesterol, systolic blood pressure, smoking, alcohol, diabetes, history of cardiovascular disease or cancer, supplement use, physical activity, and housing tenure
                    Plasma 372 nmol/L Quintile 5 vs. Q1; 772/153 Both Age, sex, body mass index, cholesterol, systolic blood pressure, smoking, alcohol, diabetes, and history of cardiovascular disease or cancer, physical activity, housing tenure, vitamin supplementation.
7 Todd, 1999 UK SHHS Not available 7.7 99.90% 11629 591 40–59 FFQ 2967.7 ug/d Quartile 4 vs. Q1 Both Age, serum total cholesterol, systolic btood pressure, carbon monoxide, energy, previous medical diagnosis of diabetes, body mass index, the Bortner personality score, trigtycerides, high density llpoproteln cholesterol, fSrinogen, a self-reported measure of activity in leisure, and alcohol consumption
8 Goyal, 2013 US NHANES III 78% 14.2 96.70% 16008 4225 >20 Serum 368 nmol/L Quintile 5 vs. Q1; >520/<130 Both Age, sex, race-ethnicity, level of education, annual family income, body mass index, smoking status, serum cotinine level, alcohol consumption, fruit and vegetable intake, physical activity, serum total cholesterol levels, hypertension status, diabetes status, history of heart attack, congestive heart failure, stroke or cancer, hormone use in women, and supplement use
9 Bates, 2011 UK BNDNs 99.80% 13.5 94.50% 1054 717 >65 Plasma 363 nmol/L per SD Both Age and sex
10 Huerta, 2006 Spain Asturias Not available 4.3 96.00% 154 31 61.5–79.8 Serum 168 nmol/L Tertile 3 vs. T1; >177.51/<87 Both Age, sex, body mass index, self-perceived health, alcohol consumption, practice of daily exercise, diabetes, use of antihypertensive drugs, plasma albumin concentration, plasma lipids.
11 Ito, 2002 Japan CHEP (1990–1994) Not available 6–10 90.50% 2444 146 39–80 Serum 455 nmol/L Tertile 3 vs. T1 Both Age, sex, habits of smoking and alcohol consumption, and serum levels of total cholesterol and GPT activity
12 Kilander, 2001 Sweden Uppsala 82.00% 22.7–25.7 100.00% 2285 630 48.6–51.1 Serum 302 nmol/L per SD Male Age
13 Ito, 1997 Japan CHEP (1986–1989) Not available 2–8 Not available 2348 98 39–83 Serum 666 nmol/L Highest vs. Lowest group; Male, >592/266; Female, 1266/682 Both Age, sex, smoking, alcohol drinking.

Abbreviation: FFQ, food frequency questionaire; SD, standard deviation; M, male; F, female.